Cotización Sunshine Biopharma - SBFM

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

0.28

Postura de Compra

0.2721

Postura de Venta

0.28

Volume Operado de la Acción

2,639

0.00 Rango del Día 0.00

0.266 Rango de 52 semanas 64.50

Capitalización de Mercado [m]

5.305M

Precio Anterior

0.2691

Precio de Apertura

Hora

108

0.28

(formt)

Última hora de negociación

07:12:28

Volumen financiero

Precio Promedio Ponderado

Volumen promedio (3 m)

2,551,789

Acciones en circulación

18,945,052

Rendimiento del Dividendo

Ratio Precio/Utilidad

-1.14

Beneficio por acción (BPA)

-0.24

turnover

24.09M

Beneficio neto

-4.51M

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of ... Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). Mostrar más

Sector

Coml Physical, Biologcl Resh

Industria

Coml Physical, Biologcl Resh

Sitio web

www.sunshinebiopharma.com

Sede

Montreal, Quebec, Can

Fundado

1970

Sunshine Biopharma Inc is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker SBFM. The last closing price for Sunshine Biopharma was US$0.27. Over the last year, Sunshine Biopharma shares have traded in a share price range of US$ 0.266 to US$ 64.50.

Sunshine Biopharma currently has 18,945,052 shares in issue. The market capitalisation of Sunshine Biopharma is US$5.10 million. Sunshine Biopharma has a price to earnings ratio (PE ratio) of -1.14.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.0152	-5.14905149051	0.2952	0.3097	0.266	737515	0.28757965	CS
4	-0.04	-12.5	0.32	0.3798	0.266	807741	0.32111429	CS
12	-0.6503	-69.9021820918	0.9303	1.16	0.266	2551789	0.53881653	CS
26	-25.22	-98.9019607843	25.5	26.99	0.266	14049621	7.20199896	CS
52	-50.72	-99.4509803922	51	64.5	0.266	7050835	7.53182086	CS
156	-274.72	-99.8981818182	275	987	0.266	4403518	159.70006028	CS
260	-274.72	-99.8981818182	275	987	0.266	4403518	159.70006028	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
BBLGBone Biologics Corporation	US$ 3.38 (56.48%)	15.59M
RDHLRedhill Biopharma Ltd	US$ 0.5669 (47.59%)	23.14M
IMRXImmuneering Corporation	US$ 1.50 (32.74%)	9.89M
CDNACareDx Inc	US$ 26.20 (31.07%)	22.21k
GLMDGalmed Pharmaceuticals Ltd	US$ 0.3768 (22.58%)	749
ALXOALX Oncology Holdings Inc	US$ 3.16 (-34.17%)	440.95k
VWEVintage Wine Estates Inc	US$ 0.0348 (-32.95%)	5.03M
NCNCnoco noco Inc	US$ 0.2053 (-28.47%)	1.74M
LIPOLipella Pharmaceuticals Inc	US$ 0.6668 (-21.65%)	165.59k
NVANova Minerals Limited	US$ 4.18 (-18.20%)	1
HUGEFSD Pharma Inc	US$ 0.1218 (20.59%)	46.75M
RDHLRedhill Biopharma Ltd	US$ 0.5669 (47.59%)	23.14M
BBLGBone Biologics Corporation	US$ 3.38 (56.48%)	15.59M
NVDANVIDIA Corporation	US$ 120.23 (2.74%)	11.72M
IMRXImmuneering Corporation	US$ 1.50 (32.74%)	9.89M